These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29629569)

  • 1. Reversible versus irreversible inhibition modes of ERK2: a comparative analysis for ERK2 protein kinase in cancer therapy.
    Khan S; Bjij I; Betz RM; Soliman ME
    Future Med Chem; 2018 May; 10(9):1003-1015. PubMed ID: 29629569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling and crystal structure of ERK2-hypothemycin complexes.
    Rastelli G; Rosenfeld R; Reid R; Santi DV
    J Struct Biol; 2008 Oct; 164(1):18-23. PubMed ID: 18571434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5Z-7-Oxozeaenol covalently binds to MAP2K7 at Cys218 in an unprecedented manner.
    Sogabe Y; Matsumoto T; Hashimoto T; Kirii Y; Sawa M; Kinoshita T
    Bioorg Med Chem Lett; 2015 Feb; 25(3):593-6. PubMed ID: 25529738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological concentrations of divalent magnesium ion activate the serine/threonine specific protein kinase ERK2.
    Waas WF; Dalby KN
    Biochemistry; 2003 Mar; 42(10):2960-70. PubMed ID: 12627962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Conformational Flexibility on Binding Free Energy Estimation between Kinases and Their Inhibitors.
    Araki M; Kamiya N; Sato M; Nakatsui M; Hirokawa T; Okuno Y
    J Chem Inf Model; 2016 Dec; 56(12):2445-2456. PubMed ID: 28024406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computational workflow for the design of irreversible inhibitors of protein kinases.
    Del Rio A; Sgobba M; Parenti MD; Degliesposti G; Forestiero R; Percivalle C; Conte PF; Freccero M; Rastelli G
    J Comput Aided Mol Des; 2010 Mar; 24(3):183-94. PubMed ID: 20306284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol.
    Wu J; Powell F; Larsen NA; Lai Z; Byth KF; Read J; Gu RF; Roth M; Toader D; Saeh JC; Chen H
    ACS Chem Biol; 2013 Mar; 8(3):643-50. PubMed ID: 23272696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Investigations on Reaction Mechanisms of the Covalent Inhibitors Ponatinib and Analogs Targeting the Extracellular Signal-Regulated Kinases.
    Tian Y; Zhang M; Heng P; Hou H; Wang B
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of a cysteine residue in the active site of ERK and the MAPKK family.
    Ohori M; Kinoshita T; Yoshimura S; Warizaya M; Nakajima H; Miyake H
    Biochem Biophys Res Commun; 2007 Feb; 353(3):633-7. PubMed ID: 17194451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow inhibition and conformation selective properties of extracellular signal-regulated kinase 1 and 2 inhibitors.
    Rudolph J; Xiao Y; Pardi A; Ahn NG
    Biochemistry; 2015 Jan; 54(1):22-31. PubMed ID: 25350931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the Chemical Space of ERK2 Kinase Inhibitors Using Descriptors Computed from Molecular Dynamics Trajectories.
    Ash J; Fourches D
    J Chem Inf Model; 2017 Jun; 57(6):1286-1299. PubMed ID: 28471171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico screening and study of novel ERK2 inhibitors using 3D QSAR, docking and molecular dynamics.
    Larif S; Salem CB; Hmouda H; Bouraoui K
    J Mol Graph Model; 2014 Sep; 53():1-12. PubMed ID: 25064438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation, semisynthesis, covalent docking and transforming growth factor beta-activated kinase 1 (TAK1)-inhibitory activities of (5Z)-7-oxozeaenol analogues.
    Fakhouri L; El-Elimat T; Hurst DP; Reggio PH; Pearce CJ; Oberlies NH; Croatt MP
    Bioorg Med Chem; 2015 Nov; 23(21):6993-9. PubMed ID: 26481152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies.
    Aly AA; El-Sheref EM; Bakheet MEM; Mourad MAE; Brown AB; Bräse S; Nieger M; Ibrahim MAA
    Bioorg Chem; 2018 Dec; 81():700-712. PubMed ID: 30268050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-apoptotic protein PEA-15 is a tight binding inhibitor of ERK1 and ERK2, which blocks docking interactions at the D-recruitment site.
    Callaway K; Abramczyk O; Martin L; Dalby KN
    Biochemistry; 2007 Aug; 46(32):9187-98. PubMed ID: 17658892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
    Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP
    Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halogen Bonding in Haspin-Halogenated Tubercidin Complexes: Molecular Dynamics and Quantum Chemical Calculations.
    Zhou Y; Wong MW
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure based designing of thiazolidinone-pyrimidine derivatives as ERK2 inhibitors: Synthesis and in vitro evaluation.
    Pathania S; Singh PK; Narang RK; Rawal RK
    SAR QSAR Environ Res; 2021 Oct; 32(10):793-816. PubMed ID: 34583590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
    Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
    Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.